Vienna-based biotech spin-off developing a novel transcriptomic-dynamics platform to identify and develop first-in-class drug candidates, primarily focused on oncology with plans to expand into autoimmune and inflammatory diseases.
Investment Rounds
Capital activity and funding progression
| Amount | Date | Round |
|---|---|---|
| not disclosed | Nov, 2025 | unspecified |
Industries
Frequently Asked Questions
What industries does Quantro Therapeutics operate in?
Quantro Therapeutics operates in the following industries: biotechnology, drug-discovery, medtech, pharmaceuticals.
When was Quantro Therapeutics founded?
Quantro Therapeutics was founded on 2025-11-27.
Who are the investors in Quantro Therapeutics?
The investors in Quantro Therapeutics are: Boehringer Ingelheim Venture Fund (BIVF), Evotec.